{
    "clinical_study": {
        "@rank": "107540", 
        "arm_group": [
            {
                "arm_group_label": "Deanxit(for dyspepsia symptoms) + Omeprazole", 
                "arm_group_type": "Active Comparator", 
                "description": "Prescribe antidepressant drug(Flupentixol and Melitracen Tablets) and proton pump inhibitor(Omeprazole). Tell the patients that they took Deanxit because of their dyspepsia symptoms and study has shown that Deanxit are effective to \tfunctional dyspepsia patients."
            }, 
            {
                "arm_group_label": "Deanxit(for depression symptoms) + Omeprazole", 
                "arm_group_type": "Active Comparator", 
                "description": "Prescribe antidepressant drug(Flupentixol and Melitracen Tablets) and proton pump inhibitor(Omeprazole). Tell the patients that they took Deanxit because of their depressant symptoms."
            }, 
            {
                "arm_group_label": "Deanxit(without explanation) + Omeprazole", 
                "arm_group_type": "Active Comparator", 
                "description": "Prescribe antidepressant drug(Flupentixol and Melitracen Tablets) and proton pump inhibitor(Omeprazole). Don't inform the patients the reason we prescribe Deanxit."
            }, 
            {
                "arm_group_label": "proton pump inhibitor", 
                "arm_group_type": "Active Comparator", 
                "description": "Prescribe  Omeprazole."
            }
        ], 
        "brief_summary": {
            "textblock": "The study hypothesis is informing patients that they are given the antidepressant drug\n      because of their dyspepsia symptoms when prescribing would receive best compliance to the\n      antidepressant drug."
        }, 
        "brief_title": "Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Dyspepsia", 
            "Compliance", 
            "Depression"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Dyspepsia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Antidepressive agents have been proved to be effective in the treatment of functional\n      dyspepsia (FD) patients. However, one of the factors that limit therapeutic benefit is the\n      poor compliance with prescribed drugs. The possible reasons for lack of compliance include\n      the patient's health beliefs (e.g., that people who took such agents is possibly considered\n      insane in China), lack of knowledge about antidepressants (that they are addictive or can be\n      stopped on recovery), and aversion to side effects. The investigators propose to examine\n      whether different prescribing behaviors could affect adherence to antidepressant drugs in\n      functional dyspepsia patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  functional dyspepsia ROME III criteria\n\n          -  All patients were seen by a psychiatrist for a structured psychiatric interview\n\n        Exclusion Criteria:\n\n          -  received antidepressant or antianxiety drug within 3 months\n\n          -  have organic or other functional disease\n\n          -  pregnant or breast-feeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01851863", 
            "org_study_id": "RJYYXHNK-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "proton pump inhibitor", 
                "description": "Prescribe Omeprazole(20mg, po, qd, 30min before breakfast).", 
                "intervention_name": "Omeprazole", 
                "intervention_type": "Drug", 
                "other_name": "Brand name: Aoke (produced by Changzhou Siyao Pharm, China)"
            }, 
            {
                "arm_group_label": "Deanxit(for dyspepsia symptoms) + Omeprazole", 
                "description": "Prescribe Flupentixol and Melitracen Tablets(one tablet, po, qd, 1 hour after breakfast) and Omeprazole (20mg, po, qd, 30min before breakfast). Tell the patients that they took Deanxit because of their dyspepsia symptoms and study has shown that Deanxit are effective to functional dyspepsia patients.", 
                "intervention_name": "Flupentixol and Melitracen Tablets(for dyspepsia symptoms) + Omeprazole", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Flupentixol and Melitracen Tablets brand name: Deanxit(produced by H.Lundbeck A/S, Copenhagen, Denmark )", 
                    "Omeprazole brand name: Aoke (produced by Changzhou Siyao Pharm, China)"
                ]
            }, 
            {
                "arm_group_label": "Deanxit(for depression symptoms) + Omeprazole", 
                "description": "Prescribe Flupentixol and Melitracen Tablets(one tablet, po, qd, 1 hour after breakfast) and Omeprazole (20mg, po, qd, 30min before breakfast). Tell the patients that they took Deanxit because of their depressant symptoms.", 
                "intervention_name": "Flupentixol and Melitracen Tablets(for depression symptoms) + Omeprazole", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Flupentixol and Melitracen Tablets brand name: Deanxit(produced by H.Lundbeck A/S, Copenhagen, Denmark )", 
                    "Omeprazole brand name: Aoke (produced by Changzhou Siyao Pharm, China)"
                ]
            }, 
            {
                "arm_group_label": "Deanxit(without explanation) + Omeprazole", 
                "description": "Prescribe  Flupentixol and Melitracen Tablets(one tablet, po, qd, 1 hour after breakfast) and Omeprazole (20mg, po, qd, 30min before breakfast). Don't inform the patients the reason of prescribing Deanxit.", 
                "intervention_name": "Flupentixol and Melitracen Tablets(without explanation) + Omeprazole", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Flupentixol and Melitracen Tablets brand name: Deanxit(produced by H.Lundbeck A/S, Copenhagen, Denmark )", 
                    "Omeprazole brand name: Aoke (produced by Changzhou Siyao Pharm, China)"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antidepressive Agents", 
                "Flupenthixol", 
                "Flupenthixol decanoate", 
                "Omeprazole", 
                "Proton Pump Inhibitors"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "functional dyspepsia", 
            "depression", 
            "compliance"
        ], 
        "lastchanged_date": "May 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China"
                }, 
                "name": "Renji Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "4", 
        "official_title": "Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia: A Randomized Comparison of Different Prescribing Behaviors", 
        "overall_contact": {
            "email": "joyceyan0532@126.com", 
            "last_name": "Xiujuan Yan"
        }, 
        "overall_official": {
            "affiliation": "RenJi Hospital", 
            "last_name": "Shengliang Chen", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "At each visit (weeks 1, 2, 4, 8, and 12), the patient bring back the drug bottle, then the physician recorded the number of pills remaining in the bottle. Patients were categorized as compliant if they returned less than 20%. Pills remained more than 20% or seven days of consecutive abstinence were adopted as the criterion for identifying therapy noncompliance.", 
            "measure": "compliance of antidepressant medication", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01851863"
        }, 
        "responsible_party": {
            "investigator_affiliation": "RenJi Hospital", 
            "investigator_full_name": "Shengliang Chen", 
            "investigator_title": "professor,chief physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Dyspepsia symptoms were evaluated with a self-recorded questionnaire at baseline and each visit. The symptom questionnaire consisted of 8 questions related to upper gastrointestinal tract symptoms: belching, bloating, early satiety, epigastric pain, burning, nausea, postprandial fullness and vomiting . They were rated according to 4 grades: 0 = absent, 1 = mild (do not affect work or life), 2 = middle (affect work and life) and 3 = severe (cannot endure). The symptom scores were calculated as severity grade \u00d7 frequency per week.", 
                "measure": "dyspepsia symptom questionnaire", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Each patient was surveyed using the Hospital Anxiety and Depression Scale to assess the psychiatric symptom at baseline and each visit.", 
                "measure": "psychiatric symptom on  Hospital Anxiety and Depression Scale", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "The 36-item Short-Form Health Survey Questionnaire was completed for rating health-related quality of life by each patient at baseline and at each visit.", 
                "measure": "quality of life rating", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "The adverse reactions were recorded to analyze the safety profile of treatment.", 
                "measure": "adverse reaction", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "RenJi Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "RenJi Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}